Detalles de la búsqueda
1.
Immunogenicity and Safety of 10-valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Administered to Children With Sickle Cell Disease Between 8 Weeks and 2 Years of Age: A Phase III, Open, Controlled Study.
Pediatr Infect Dis J
; 36(5): e136-e150, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28403055
Resultados
1 -
1
de 1
1
Próxima >
>>